On July 27, 2026, Avanos Medical, Inc. completed its merger with a subsidiary of American Industrial Partners (AIP), resulting in the company becoming a wholly-owned private subsidiary. Public shareholders received $25.00 per share in cash, representing an aggregate transaction value of approximately $1.2 billion to $1.272 billion. Concurrently, Avanos entered into a new credit agreement providing $675 million in initial term loans, $100 million in delayed draw commitments, and a $100 million revolving facility, while repaying all prior debt. Trading of Avnos common stock was suspended on the NYSE, and the company intends to deregister its securities with the SEC. The existing board resigned and was replaced by appointees from AIP, including David C. Pacitti as CEO. Avanos Medical operates in the medical technology industry, developing and manufacturing medical device solutions for patient nutrition and pain management.

Avanos Medical, Inc. stockholders have approved the pending acquisition of the company by affiliates of American Industrial Partners (AIP) for $25.00 per share in cash. The transaction is expected to close no later than July 27, 2026. Avanos Medical, Inc. is a medical technology company that develops, manufactures, and markets medical device solutions.

Avanos Medical, Inc. issued a supplement to its Definitive Proxy Statement to address litigation and demand letters from stockholders alleging disclosure deficiencies regarding its proposed merger with A-AV Holdco I, Inc. The company denies all allegations but is providing additional information to mitigate litigation risks and delays. The supplement includes updated background information regarding discussions with AIP and UBS, revised financial forecasts for Adjusted EBITDA, and updated fairness opinions from J.P. Morgan Securities LLC. J.P. Morgan's analysis indicated an implied per share equity value range of $12.75 to $23.50, compared to the $25.00 per share merger consideration. Avanos Medical, Inc. is a medical technology company.

Avanos Medical, Inc. announced on July 2, 2026, that it has received all required regulatory approvals to complete its pending acquisition by affiliates of investment funds advised by American Industrial Partners. Avanos Medical, Inc. operates in the medical technology industry and develops products for pain management and gastrointestinal health.